Ista Pharmaceuticals, Inc. (ISTA) Tops Q4 EPS by 4c, Sales Miss Expectations

Ista Pharmaceuticals, Inc. (NASDAQ: ISTA) reported Q4 EPS of $0.25, $0.04 better than the analyst estimate of $0.21. Revenue for the quarter came in at $45.1 million versus the consensus estimate of $46.55 million.

For earnings history and earnings-related data on Ista Pharmaceuticals, Inc. (ISTA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Logistic Properties of the Americas (LPA) Reports Q2 results
• Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02